Stay informed with expert insights, trends, and best practices in life sciences compliance.
The EFPIA Transparency Directive deems it necessary for all member associations within the EU to publish spend data by Pharma manufacturers on HCP/HCO. For this purpose, under the data privacy laws of the EU, it is necessary for pharmaceutical manufacturers to receive consent from HCPs prior to reporting any transfer of value details in the […]
The 4th Annual Pharma Compliance Europe Congress is being held at the Royal Garden Hotel, London, UK, on October 5th & 6th, 2016. The conference aims to bring together senior representatives from the legal, compliance, and transparency industries to discuss operational best practices and will feature an impressive list of speakers and attendees from Pfizer, […]
In the past couple of years, law enforcement agencies have recovered billions of dollars through judgments and settlements related to healthcare fraud investigations. In the fiscal year 2015, the DoJ recovered more than $3.5 billion in judgments and settlements from cases that involved fraud and false claims against the government. As time goes by, government […]
Prosecutors have indicted six executives from the South Korean unit of Novartis for paying rebates to doctors so they may prescribe the company’s drugs to patients. Twenty-eight other individuals, including fifteen doctors and six medical publishers, were also part of the prosecutorial sweep. The six executives who were prosecuted include Novartis Korea chief Moon Hak-sun. […]
CBI held the 10th Annual Forum on Transparency and Aggregate Spend at the Ritz-Carlton in Washington, D.C. from 15th – 17th August, 2016. The forum provided an excellent opportunity for pharmaceutical, biotech, and medical device executives to connect and share information about best practices pertaining to Federal, State, and worldwide HCP reporting. The conference delivered […]
The relationship between the life sciences industry and healthcare professionals is complex, involving various financial transactions that can potentially influence medical decisions. To address concerns about conflicts of interest in healthcare, Congress enacted the Physician Payments Sunshine Act (PPSA) in March 2010 as part of the Patient Protection and Affordable Care Act (ACA). The Sunshine […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 0. All rights reserved | Sitemap | Privacy Policy | Terms of Use